Date:11/4/2011

orward-looking statements." Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties which may cause Volcano's results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ include the pace and extent of market adoption of the company's products and technologies, growth strategies, timing and achievement of product development milestones, the impact and benefits of market development, product introductions, unexpected new data, safety and technical issues, market conditions, dependence on third parties, and other risks inherent to medical device development and commercialization. These and additional risks and uncertainties are more fully described in Volcano's filings made with the Securities and Exchange Commission, including our  recent quarterly report on Form 10-Q. Undue reliance should not be placed on forward-looking statements which speak only as of the date they are made. Volcano undertakes no obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they are made, or to reflect the occurrence of unanticipated events.

'/>"/>

SOURCE Volcano Corporation Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine technology :

1. Volcano Reports 18 Percent Increase in Total Third Quarter Revenues
2. Volcano Corporation Appoints Leslie V. Norwalk and Dr. Eric J. Topol to Board of Directors
3. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
4. Volcano Corporation Announces Presentations at Upcoming Investor Conferences
5. Volcano Reports 22 Percent Increase in Second Quarter Medical Segment Revenues and Earnings per share of $0.09
6. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
7. Volcano Corporation Presentation at William Blair Conference to be Webcast
8. Volcano Corporation Presentation at Goldman Sachs Conference to be Webcast
9. Statement From Volcano Corporation on Latest St. Jude Lawsuit
10. Volcano to Highlight its Precision Guided Therapy Technologies at EuroPCR
11. Volcano Achieves 22 Percent Increase in First Quarter Revenues; Sales Growth, Margin Expansion Drive Profitability